Waturu Holding A/S – activity update
Company announcement No. 32
Vejle, June 9. 2020
Follow-up regarding production setup (follow-up to company announcement no. 22)
Delay in the setup of the automated production, as described in the company announcement of December 23, 2019, has led to delayed sales. Subsequent challenges with the supply of components and further exacerbated by the impact of the Corona crisis mean that delivery of units will commence in Q3 2020.Test results in Watgen Medical A/S – reduction of bacteria in blood
Watgen Medical A/S, together with Bioneer A/S, carried out testing of the company’s technology, to investigate the possibility of reducing bacteria in blood, without destroying the proteins in the blood. 18 L of horse blood was tested and various bacteria were added. An OEM prototype was used and the blood was processed only once at relatively low wattage.About Waturu Holding A/S
Waturu Holding A/S is a Vejle based Greentech company, which develops innovative water technology for heating or treating water, with the focus on ensuring bacteria-free water and reducing water and energy consumption for heating hot water in properties and thus ensuring CO2 savings. Waturu Holding A/S is a major shareholder in the medical company Watgen Medical A/S and in the technology company Aquaturu A/S.Further information:
CEO Toke Reedtz, cell.: +45 5188 1262, e-mail: toke@waturu.com
CFO Michael Nørgaard, cell.: +45 2720 6214, e-mail: mn@waturu.comWaturu Holding A/S
Sjællandsgade 32
7100 VejleCertified Adviser
Tofte & Company ApS
Christian IX Gade 7, 3rd,
1111 København
Phone.: +45 71961030
Contact: Sasja Dalgaard, mobile: +45 26100877, e-mail: sd@toftecompany.com
Website: toftecompany.com
Vejle, June 9. 2020
Follow-up regarding production setup (follow-up to company announcement no. 22)
Delay in the setup of the automated production, as described in the company announcement of December 23, 2019, has led to delayed sales. Subsequent challenges with the supply of components and further exacerbated by the impact of the Corona crisis mean that delivery of units will commence in Q3 2020.Test results in Watgen Medical A/S – reduction of bacteria in blood
Watgen Medical A/S, together with Bioneer A/S, carried out testing of the company’s technology, to investigate the possibility of reducing bacteria in blood, without destroying the proteins in the blood. 18 L of horse blood was tested and various bacteria were added. An OEM prototype was used and the blood was processed only once at relatively low wattage.About Waturu Holding A/S
Waturu Holding A/S is a Vejle based Greentech company, which develops innovative water technology for heating or treating water, with the focus on ensuring bacteria-free water and reducing water and energy consumption for heating hot water in properties and thus ensuring CO2 savings. Waturu Holding A/S is a major shareholder in the medical company Watgen Medical A/S and in the technology company Aquaturu A/S.Further information:
CEO Toke Reedtz, cell.: +45 5188 1262, e-mail: toke@waturu.com
CFO Michael Nørgaard, cell.: +45 2720 6214, e-mail: mn@waturu.comWaturu Holding A/S
Sjællandsgade 32
7100 VejleCertified Adviser
Tofte & Company ApS
Christian IX Gade 7, 3rd,
1111 København
Phone.: +45 71961030
Contact: Sasja Dalgaard, mobile: +45 26100877, e-mail: sd@toftecompany.com
Website: toftecompany.com
